| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.45 | 0.003 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.46 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |